Lyme Disease Vaccine Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lyme Disease Vaccine Market Report 2026

Name: Lyme Disease Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vaccine Type (Recombinant Vaccines, Subunit Vaccines, Live Attenuated Vaccines, Other Vaccine Types), By Technology (Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Nucleic Acid Test, Serological Test), By Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospitals And Clinics, Pharmacies, Government Supply, Other Distribution Channels), By End User (Hospitals, Clinical Laboratories, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Lyme Disease Vaccine Market Overview

• Lyme Disease Vaccine market size has reached to $1.12 billion in 2025

• Expected to grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Increasing Prevalence Of Lyme Disease Fueling The Growth Of The Market Due To Climate-Driven Expansion Of Tick Habitats

• Market Trend: Positive Phase 2 Data Highlights Strong Immune Response And Safety Of Booster Dose

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lyme Disease Vaccine Market?

Lyme disease vaccine refers to biological preparations designed to stimulate the immune system to recognize and fight Borrelia burgdorferi, the bacteria responsible for Lyme disease, thereby preventing infection following a tick bite. These vaccines work by triggering the production of specific antibodies that neutralize the bacteria, reducing the risk of disease transmission and associated complications, and serve as an important tool in controlling Lyme disease in endemic regions.

The main vaccine types of Lyme disease vaccine are recombinant vaccines, subunit vaccines, live attenuated vaccines, and others. Recombinant vaccines refer to vaccines developed by using genetic engineering techniques to produce specific proteins (antigens) from Borrelia burgdorferi, the bacteria that cause Lyme disease. It utilizes various technologies such as lymphocytic transformation test, urine antigen testing, immunofluorescent staining nucleic acid test, and serological test, serving age groups such as pediatric, adult, and geriatric. It is distributed through various channels, including hospitals and clinics, pharmacies, government supply, and others, catering to end users such as hospitals, clinical laboratories, and others.

Lyme Disease Vaccine Market Global Report 2026 Market Report bar graph

What Is The Lyme Disease Vaccine Market Size and Share 2026?

The lyme disease vaccine market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing incidence of lyme disease in endemic regions, historical limitations of antibiotic-only treatment approaches, early-stage vaccine research initiatives, growing awareness of tick-borne infections, public health surveillance improvements.

What Is The Lyme Disease Vaccine Market Growth Forecast?

The lyme disease vaccine market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to expansion of vaccination programs in endemic areas, increasing investment in infectious disease prevention, advancement of next-generation vaccine platforms, rising adoption of combination vaccines, growing global focus on zoonotic disease control. Major trends in the forecast period include advancement of recombinant vaccine technologies, increased focus on preventive immunization programs, expansion of clinical research for tick-borne diseases, growing emphasis on long-lasting immunity solutions, rising collaboration between public and private health organizations.

Book your 30 minutes free consultation with our research experts

Global Lyme Disease Vaccine Market Segmentation

1) By Vaccine Type: Recombinant Vaccines, Subunit Vaccines, Live Attenuated Vaccines, Other Vaccine Types

2) By Technology: Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Nucleic Acid Test, Serological Test

3) By Age Group: Pediatric, Adult, Geriatric

4) By Distribution Channel: Hospitals And Clinics, Pharmacies, Government Supply, Other Distribution Channels

5) By End User: Hospitals, Clinical Laboratories, Other End Users

Subsegments:

1) By Recombinant Vaccines: Protein-Based Recombinant Vaccines, Vector-Based Recombinant Vaccines, Deoxyribonucleic Acid (DNA)-Based Recombinant Vaccines

2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugate Subunit Vaccines

3) By Live Attenuated Vaccines: Naturally Attenuated Vaccines, Genetically Attenuated Vaccines, Temperature-Sensitive Attenuated Vaccines

4) By Other Vaccine Types: Toxoid Vaccines, Inactivated Vaccines, Vectored Vaccines

What Are The Drivers Of The Lyme Disease Vaccine Market?

The increasing prevalence of Lyme disease is expected to propel the growth of the Lyme disease vaccine market going forward. Lyme disease is a tick-borne infection caused by Borrelia bacteria, leading to fever, fatigue, rash, and potentially serious joint, heart, or nerve problems if untreated. The increasing prevalence of Lyme disease is due to climate change as warmer temperatures and milder winters expand tick habitats, increasing human exposure to infected ticks. Lyme disease vaccines aid in Lyme disease prevention by training the immune system to recognize and fight Borrelia bacteria, reducing the risk of infection. They simplify disease management by providing long-term protection, improving public health outcomes. For instance, in March 2025, according to the Centers for Disease Control and Prevention, a US-based federal health agency, in 2023, around 89,000 cases of Lyme disease were reported in the United States, while estimates using other methods suggest that approximately 476,000 people may be diagnosed and treated for Lyme disease each year. Therefore, the increasing Lyme disease prevalence is driving the growth of the Lyme disease vaccine industry.

The rising healthcare expenditure is expected to propel the growth of the Lyme disease vaccine market going forward. Healthcare expenditure refers to the total amount of money spent on medical services, treatments, facilities, research, and public health initiatives to maintain or improve health outcomes. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances Lyme disease vaccine development by providing increased funding for research and clinical trials, accelerating innovation and production. It supports advanced vaccine technologies, improving accessibility and effectiveness for at-risk populations. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the Lyme disease vaccine industry.

Key Players In The Global Lyme Disease Vaccine Market

Major companies operating in the lyme disease vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Boehringer Ingelheim GmbH, University of Pennsylvania, Elanco Animal Health Incorporated, Zoetis Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Life Inc., Bioveta a.s., Dynavax Technologies Corporation, Valneva SE, MassBiologics of UMass Chan Medical School, Inovio Pharmaceuticals Inc., US Biologic Inc., Blue Lake Biotechnology Inc.

Global Lyme Disease Vaccine Market Trends and Insights

Major companies operating in the Lyme disease vaccine market are focusing on advancing their late-stage product candidates, such as booster vaccines, to address unmet medical needs, enhance immune protection, and simplify vaccination regimens. Booster vaccines are additional doses given after the initial vaccination to restore or enhance long-term immunity. For instance, in September 2025, Valneva SE, a France-based biotechnology company, confirmed the positive immunogenicity and safety data from the ongoing Phase 2 study of Lyme disease vaccine candidate, VLA15. It is a multivalent vaccine that trains the immune system to produce antibodies against OspA proteins on Borrelia bacteria. When a tick bites, these antibodies block the bacteria inside the tick, preventing infection in humans. The strong immune response and favorable safety profile following a third booster dose were consistent with those reported after receiving previous annual booster doses, further demonstrating compatibility with the anticipated benefits of a yearly vaccination prior to each Lyme season. This booster strategy is intended to provide continued protection against Lyme disease, supporting the potential for an annual pre-exposure season booster to simplify protection for at-risk individuals.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the Lyme disease vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lyme Disease Vaccine Market?

The Lyme disease vaccine market consists of sales of pre-filled syringes, single or multi-dose vials, vaccine kits, storage and delivery equipment, and cold-chain packaging materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lyme Disease Vaccine Market Report 2026?

The lyme disease vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Lyme Disease Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.2 billion
Revenue Forecast In 2035	$1.57 billion
Growth Rate	CAGR of 7.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vaccine Type, Technology, Age Group, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Boehringer Ingelheim GmbH, University of Pennsylvania, Elanco Animal Health Incorporated, Zoetis Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Life Inc., Bioveta a.s., Dynavax Technologies Corpor
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lyme Disease Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lyme Disease Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lyme Disease Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lyme Disease Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Advancement Of Recombinant Vaccine Technologies

4.2.2 Increased Focus On Preventive Immunization Programs

4.2.3 Expansion Of Clinical Research For Tick-Borne Diseases

4.2.4 Growing Emphasis On Long-Lasting Immunity Solutions

4.2.5 Rising Collaboration Between Public And Private Health Organizations

5. Lyme Disease Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinical Laboratories

5.3 Government Health Agencies

5.4 Research Institutes

5.5 Vaccination Centers

6. Lyme Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lyme Disease Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lyme Disease Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lyme Disease Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lyme Disease Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lyme Disease Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lyme Disease Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lyme Disease Vaccine Market Segmentation

9.1. Global Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Vaccines, Subunit Vaccines, Live Attenuated Vaccines, Other Vaccine Types

9.2. Global Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Nucleic Acid Test, Serological Test

9.3. Global Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Geriatric

9.4. Global Lyme Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Pharmacies, Government Supply, Other Distribution Channels

9.5. Global Lyme Disease Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinical Laboratories, Other End Users

9.6. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein-Based Recombinant Vaccines, Vector-Based Recombinant Vaccines, Deoxyribonucleic Acid (DNA)-Based Recombinant Vaccines

9.7. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugate Subunit Vaccines

9.8. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Naturally Attenuated Vaccines, Genetically Attenuated Vaccines, Temperature-Sensitive Attenuated Vaccines

9.9. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Toxoid Vaccines, Inactivated Vaccines, Vectored Vaccines

10. Lyme Disease Vaccine Market Regional And Country Analysis

10.1. Global Lyme Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lyme Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lyme Disease Vaccine Market

11.1. Asia-Pacific Lyme Disease Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lyme Disease Vaccine Market

12.1. China Lyme Disease Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lyme Disease Vaccine Market

13.1. India Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lyme Disease Vaccine Market

14.1. Japan Lyme Disease Vaccine Market Overview

14.2. Japan Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lyme Disease Vaccine Market

15.1. Australia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lyme Disease Vaccine Market

16.1. Indonesia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lyme Disease Vaccine Market

17.1. South Korea Lyme Disease Vaccine Market Overview

17.2. South Korea Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lyme Disease Vaccine Market

18.1. Taiwan Lyme Disease Vaccine Market Overview

18.2. Taiwan Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lyme Disease Vaccine Market

19.1. South East Asia Lyme Disease Vaccine Market Overview

19.2. South East Asia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lyme Disease Vaccine Market

20.1. Western Europe Lyme Disease Vaccine Market Overview

20.2. Western Europe Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lyme Disease Vaccine Market

21.1. UK Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lyme Disease Vaccine Market

22.1. Germany Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lyme Disease Vaccine Market

23.1. France Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lyme Disease Vaccine Market

24.1. Italy Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lyme Disease Vaccine Market

25.1. Spain Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lyme Disease Vaccine Market

26.1. Eastern Europe Lyme Disease Vaccine Market Overview

26.2. Eastern Europe Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lyme Disease Vaccine Market

27.1. Russia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lyme Disease Vaccine Market

28.1. North America Lyme Disease Vaccine Market Overview

28.2. North America Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lyme Disease Vaccine Market

29.1. USA Lyme Disease Vaccine Market Overview

29.2. USA Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lyme Disease Vaccine Market

30.1. Canada Lyme Disease Vaccine Market Overview

30.2. Canada Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lyme Disease Vaccine Market

31.1. South America Lyme Disease Vaccine Market Overview

31.2. South America Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lyme Disease Vaccine Market

32.1. Brazil Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lyme Disease Vaccine Market

33.1. Middle East Lyme Disease Vaccine Market Overview

33.2. Middle East Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lyme Disease Vaccine Market

34.1. Africa Lyme Disease Vaccine Market Overview

34.2. Africa Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lyme Disease Vaccine Market Regulatory and Investment Landscape

36. Lyme Disease Vaccine Market Competitive Landscape And Company Profiles

36.1. Lyme Disease Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lyme Disease Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lyme Disease Vaccine Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.5. University of Pennsylvania Overview, Products and Services, Strategy and Financial Analysis

37. Lyme Disease Vaccine Market Other Major And Innovative Companies

Elanco Animal Health Incorporated, Zoetis Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Life Inc., Bioveta a.s., Dynavax Technologies Corporation, Valneva SE, MassBiologics of UMass Chan Medical School, Inovio Pharmaceuticals Inc., US Biologic Inc., Blue Lake Biotechnology Inc.

38. Global Lyme Disease Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lyme Disease Vaccine Market

40. Lyme Disease Vaccine Market High Potential Countries, Segments and Strategies

40.1 Lyme Disease Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Lyme Disease Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Lyme Disease Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Lyme Disease Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Lyme Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Lyme Disease Vaccine Market, Supply Chain Analysis

Table 4: Global Lyme Disease Vaccine Market, Major Raw Material Providers

Table 5: Global Lyme Disease Vaccine Market, Major Resource Providers

Table 6: Global Lyme Disease Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Lyme Disease Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Lyme Disease Vaccine Market, Key Technologies & Future Trends

Table 9: Global Lyme Disease Vaccine Market, Major Trends

Table 10: Global Lyme Disease Vaccine Market, Major End Users

Table 11: Global Lyme Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Lyme Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Lyme Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Lyme Disease Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Lyme Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Lyme Disease Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Lyme Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Lyme Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Lyme Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Lyme Disease Vaccine Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: Sanofi S.A. Financial Performance

Table 103: Boehringer Ingelheim GmbH Financial Performance

Table 104: University of Pennsylvania Financial Performance

Table 105: Global Lyme Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Lyme Disease Vaccine Market, Competitive Dashboard

Table 107: Global Lyme Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Table 109: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 110: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

Figure 1: Global Lyme Disease Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Lyme Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Lyme Disease Vaccine Market, Supply Chain Analysis

Figure 4: Global Lyme Disease Vaccine Market, Major Raw Material Providers

Figure 5: Global Lyme Disease Vaccine Market, Major Resource Providers

Figure 6: Global Lyme Disease Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Lyme Disease Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Lyme Disease Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Lyme Disease Vaccine Market, Major Trends

Figure 10: Global Lyme Disease Vaccine Market, Major End Users

Figure 11: Global Lyme Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Lyme Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Lyme Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Lyme Disease Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Lyme Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Lyme Disease Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Lyme Disease Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Lyme Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Lyme Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Lyme Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Lyme Disease Vaccine Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: Sanofi S.A. Financial Performance

Figure 103: Boehringer Ingelheim GmbH Financial Performance

Figure 104: University of Pennsylvania Financial Performance

Figure 105: Global Lyme Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Lyme Disease Vaccine Market, Competitive Dashboard

Figure 107: Global Lyme Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Figure 109: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 110: Global, Lyme Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) – Market Size, Trends, Strategies,...

Pediatric Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, ...

Adult Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Con...

Veterinary Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types), By Animal Type (Canine, Feline, Equine, Bovine...

Pertussis Vaccine Market Report 2026 - Global Outlook – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine,...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Frequently Asked Questions

How big is the Lyme Disease Vaccine Market?

The Lyme Disease Vaccine market was valued at $1.12 billion in 2025, increased to $1.2 billion in 2026, and is projected to reach $1.57 billion by 2030.

What is the Lyme Disease Vaccine market growth?

The global Lyme Disease Vaccine market is expected to grow at a CAGR of 7.0% from 2026 to 2035 to reach $1.57 billion by 2035.

Who are the key players in Lyme Disease Vaccine market?

Some Key Players in the Lyme Disease Vaccine market Include, Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Boehringer Ingelheim GmbH, University of Pennsylvania, Elanco Animal Health Incorporated, Zoetis Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Life Inc., Bioveta a.s., Dynavax Technologies Corporation, Valneva SE, MassBiologics of UMass Chan Medical School, Inovio Pharmaceuticals Inc., US Biologic Inc., Blue Lake Biotechnology Inc. .

What is the anticipated growth trend for the Lyme Disease Vaccine market?

Major trend in this market includes: Positive Phase 2 Data Highlights Strong Immune Response And Safety Of Booster Dose. For further insights on this market. request a sample here

Which region has the most growth potential in the Lyme Disease Vaccine market?

North America was the largest region in the Lyme disease vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.